CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
Tag: pancreatic cancer immunotherapy
Mutant KRAS Vaccine Boosts Pancreatic Cancer Therapy
In a monumental step forward in the battle against pancreatic cancer, researchers have unveiled a pioneering clinical trial that combines ...
Innovative Antibody Therapy Reactivates Immune Response Against Pancreatic Cancer
Pancreatic cancer continues to challenge oncologists with its aggressive nature, late diagnosis, and stubborn resistance to established treatments. While many ...
Blocking Spermine Metabolism Boosts Pancreatic Cancer Immunity
In the unrelenting battle against pancreatic cancer, a malignancy notorious for its dismal prognosis and resistance to conventional therapies, a ...
USP39: New Biomarker for Pancreatic Immunotherapy
In the relentless pursuit of precision medicine, researchers have identified a novel biomarker that holds great promise in the battle ...
Promising Results: Cancer-Fighting Implant Targets Melanoma, Pancreatic, and Colorectal Tumors
A team of innovators from Rice University is setting a new standard in oncology with the development of an implantable ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!